Intervention Review

Homeopathic medicines for adverse effects of cancer treatments

  1. Sosie Kassab1,*,
  2. Mike Cummings2,
  3. Saul Berkovitz3,
  4. Robbert van Haselen4,
  5. Peter Fisher1

Editorial Group: Cochrane Pain, Palliative and Supportive Care Group

Published Online: 15 APR 2009

Assessed as up-to-date: 20 JAN 2009

DOI: 10.1002/14651858.CD004845.pub2


How to Cite

Kassab S, Cummings M, Berkovitz S, van Haselen R, Fisher P. Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD004845. DOI: 10.1002/14651858.CD004845.pub2.

Author Information

  1. 1

    Royal London Hospital for Integrated Medicine, London, UK

  2. 2

    British Medical Acupuncture Society, London, UK

  3. 3

    Royal London Homoeopathic Hospital, London, UK

  4. 4

    INTMEDI, Surrey, UK

*Sosie Kassab, Royal London Hospital for Integrated Medicine, Great Ormond Street, London, WC1N 3HR, UK. sosie.kassab@uclh.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 15 APR 2009

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.